Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells
- 6 November 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (51) , 7817-7823
- https://doi.org/10.1038/sj.onc.1205906
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growthClinical & Experimental Metastasis, 2002
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of diseaseInternational Journal of Cancer, 1996
- Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patientsInternational Journal of Cancer, 1994
- Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patientsThe Lancet, 1992
- Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.Molecular and Cellular Biology, 1990
- Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion moleculePublished by Elsevier ,1989
- Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proceedings of the National Academy of Sciences, 1987
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983